Literature DB >> 22082519

Major pulmonary embolism.

Kenneth E Wood1.   

Abstract

The scope and spectrum of pulmonary embolism (PE) that are likely to challenge the intensivist are dominantly confined to 2 scenarios; first, a patient presenting with undifferentiated shock or respiratory failure and, second, an established intensive care unit (ICU) or hospital patient who develops hemodynamically unstable PE after admission. In either scenario, the diagnostic approach and therapeutic options are challenging. Differentiating PE from other life-threatening cardiopulmonary disorders can be exceedingly difficult. This article will review a structured pathophysiologic approach to the diagnostic, resuscitative and management strategies related to PE in the ICU.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22082519     DOI: 10.1016/j.ccc.2011.09.002

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  4 in total

1.  Extracorporeal Membrane Oxygenation-First Strategy for Acute Life-Threatening Pulmonary Embolism.

Authors:  Zhenjie Liu; Jinyi Chen; Xin Xu; Fen Lan; Minzhi He; Changming Shao; Yongshan Xu; Pan Han; Yibing Chen; Yongbin Zhu; Man Huang
Journal:  Front Cardiovasc Med       Date:  2022-06-03

Review 2.  Pulmonary vascular dysfunction in ARDS.

Authors:  Donal Ryan; Stephen Frohlich; Paul McLoughlin
Journal:  Ann Intensive Care       Date:  2014-08-22       Impact factor: 6.925

3.  Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.

Authors:  Evandro M Neto-Neves; Ozelia Sousa-Santos; Karina C Ferraz; Elen Rizzi; Carla S Ceron; Minna M D Romano; Luis G Gali; Benedito C Maciel; Richard Schulz; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  J Cell Mol Med       Date:  2013-11-06       Impact factor: 5.310

4.  Cardiac Findings of Pulmonary Thromboembolism by Autopsy: A Review of 48 Cases.

Authors:  Aysun Yakar; Fatih Yakar; Nihan Ziyade; Muhlis Yıldız; İbrahim Üzün
Journal:  Med Sci Monit       Date:  2016-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.